Sat, Jan 31, 2015, 7:38 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • spOOkchaser spOOkchaser Sep 21, 2011 1:22 PM Flag

    I'm hoping --

    that this company is NOT just another big science project that went public to make the owners rich.
    I was cautious about buying until they actually shipped some units (15 or 16 ?) and had revs of more then double of estimates for last qtr.
    I felt I was just lucky to have waited until the price was cut in 1/2 to ~$6 before I bought.
    Now they claim that sales are not there and thats why the layoffs are happening.

    It is nearly impossible for a person who is not strong in the life-sciences to grasp the nuances of the biotech industry---and that includes me. This is why I never went after a biotech drug co. One bad word from the FDA and BAM! you lose 50%

    I felt that a sequencing company ( THE RIGHT ONE) would be selling hardware to MANY of the biotechs and was a safer bet. But picking the winner is a tough chore.
    I do see that ILMN took a big hit today also, so just maybe the BIG players are rotating out of the group for a while----or just picking up cheap shares as it slides.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I own GNOM. Not sure if you follow the company or not? I feel their total outsourced sequencing model allows for a more economical choice amongst research and clinical institutions.

      Rather than investing large sums of $$ upfront in sequencing equipment, personel, office space, etc, GNOM provides everything needed to analyze the gene (via the cloud) at a fraction of the cost.

      That said, it seems this space has experienced a slowdown in demand due to the overall economy and constrained research budgets. It's hard to argue with this technology being a game changer in the world of medicine, but unless folks are willign to adopt it, hard to say just when it will take off??

      • 1 Reply to spittinimage6
      • GNOM---That is an interesting business model they have ---sequencing as a service. BUT--at some point in their process, a sequencing machine has to be used. In their case it appears to be some sort of array on a chip.
        I simply cannot say if this approach is technically superior to PACB or any other approach.
        The question remains--what sequencing machine company or companies will be the ultimate winner?

        Sequencing machines are not a commodity item, so there is still major money to be made in building the hardware, and suppling the consumables (Razors & Blades analogy) Maybe the gimmick is to basically FLOOD the market with your machines and make the $$$$ with your consumables.

        My take is that there is room for a few GOOD companies to win---with some of them perhaps specializing in a specific aspect of the sequencing market.

    • Hey i don't know I agree this is a hard to pick sector but I got in with a 1k shares at $4.52 and it seem to have bottom so let's hope it head up tomorrow.

 
PACB
8.04-0.130(-1.59%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.